Hims & Hers to offer compounded GLP-1 weight-loss injections

News News

Hims & Hers to offer compounded GLP-1 weight-loss injections
United States Latest News,United States Headlines
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections as Ozempic and Wegovy soar in popularity.

Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. Shares of the company surged. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and hair loss, launched a weight loss program in December. But GLP-1 medications — such as Ozempic and Wegovy, which have skyrocketed in popularity — were not previously offered as part of that program.

The GLP-1 market, dominated so far by pharmaceutical giant Novo Nordisk, has faced supply constraints in recent months as the drugs get expanded approval from health regulators and increased health coverage. GLP-1s mimic a hormone produced in the gut to tamp down a person’s appetite and regulate their blood sugar. When those medications are in shortage, certain manufacturers can prepare a compounded version if they meet U.S. Food and Drug Administration requirements.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNewsHealth /  🏆 707. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shares of Hims & Hers Health surge 30% after startup says it will offer GLP-1 injectionsShares of Hims & Hers Health surge 30% after startup says it will offer GLP-1 injectionsThe GLP-1 market has faced supply constraints in recent months as drugs like Ozempic and Wegovy continue to skyrocket in popularity.
Read more »

Hims & Hers Health adds compounded GLP-1 injections to weight loss programHims & Hers Health adds compounded GLP-1 injections to weight loss programThe GLP-1 market has faced supply constraints in recent months as the drugs like Ozempic and Wegovy skyrocket in popularity.
Read more »

Hims & Hers Health adds compounded GLP-1 injections to weight loss programHims & Hers Health adds compounded GLP-1 injections to weight loss programThe GLP-1 market has faced supply constraints in recent months as the drugs like Ozempic and Wegovy skyrocket in popularity.
Read more »

Stocks making the biggest moves midday: Hims & Hers Health, Norwegian Cruise Line, Target, and moreStocks making the biggest moves midday: Hims & Hers Health, Norwegian Cruise Line, Target, and moreThese are the stocks posting the largest moves in midday trading.
Read more »

After-hours movers: Palantir, Microchip, Coherent, Hims & Hers HealthAfter-hours movers: Palantir, Microchip, Coherent, Hims & Hers HealthAfter-hours movers: Palantir, Microchip, Coherent, Hims & Hers Health
Read more »

Stocks making the biggest moves premarket: Walt Disney, Hims & Hers, Palantir and moreStocks making the biggest moves premarket: Walt Disney, Hims & Hers, Palantir and moreThese are the stocks posting the largest moves in early trading.
Read more »



Render Time: 2025-02-21 14:39:51